News about "biopharmaceutical "

aTyr Pharma Welcomes Eric Benevich to its Board of Directors

Benevich has served as Chief Commercial Officer of Neurocrine since May 2015 and is responsible for all aspects of commercial development, marketing, and sales of the Neurocrine product portfolio.

Biopharmaceutical | 13/12/2024 | By Aishwarya

Pulmatrix Proposes Merger Deal with Cullgen

Cullgen utilizes its proprietary technology platform, uSMITE™, featuring novel E3 ligands, to build the next generation of targeted protein degraders and degrader-antibody conjugates (DACs).

Biopharmaceutical | 16/11/2024 | By Aishwarya |  105

Huons Acquires Stake in PanGen to Expand Bio-Pharma Business

Huons will own PanGen shares through the acquisition of existing shareholders and a paid-in capital increase via third-party allocation.

Biopharmaceutical | 08/11/2024 | By Aishwarya |  118

PhotonPharma Welcomes Derek Brown as its New CEO

With more than 25 years of diverse biopharmaceutical experience across the entire product lifecycle, Derek brings a wealth of strategic, operational, and financial expertise to guide PhotonPharma through its next phase of growth.

Biopharmaceutical | 28/10/2024 | By Aishwarya |  148

Lundbeck to Acquire Longboard Pharmaceuticals to Expand its Neuroscience Pipeline

Under the terms of the agreement, Lundbeck will commence a tender offer for all outstanding shares of Longboard common stock, whereby Longboard shareholders will be offered a payment of USD 60.00 per share in cash.

Biopharmaceutical | 15/10/2024 | By Aishwarya |  191

BioMarin Strengthens its Leadership with New Appointments

At BioMarin, he will assume responsibility for the company's R&D organization, including discovery research, preclinical, translational and clinical programs, as well as global regulatory and medical affairs.

Biopharmaceutical | 22/08/2024 | By Aishwarya |  232

Sun Pharma to Invest Upto USD 15 Million for 5 Percent Stake in Pharmazz

Sun Pharma described the investment as strategic, noting it will gain exclusive rights to market and distribute Pharmazz’s drug, Sovateltide, in certain emerging markets.

Biopharmaceutical | 17/08/2024 | By Aishwarya |  215

Abzena and Argonaut to Offer End-to-End Drug Development Support for Biopharma Companies

Abzena has inked a strategic partnership with Argonaut Manufacturing Services, Inc. to provide a fully integrated drug substance and drug product manufacturing solution for biopharmaceutical organizations.

Biopharmaceutical | 21/06/2024 | By Aishwarya |  261

iOnctura Secures EUR 80 Million in Series B Financing Round

iOnctura, a clinical-stage biopharmaceutical company combating neglected and hard-to-treat cancers, has closed a EUR 80 million Series B financing.

Biopharmaceutical | 21/06/2024 | By Aishwarya |  311

Ono Announces Acquisition of Deciphera Pharmaceuticals

Ono Pharmaceutical, Co., Ltd. has completed the tender offer to acquire all outstanding shares of common stock of a US biopharmaceutical company, Deciphera Pharmaceuticals, Inc. for USD 25.60 per share (total amount of approximately USD 2.4 billion) net to the seller in cash.

Biopharmaceutical | 14/06/2024 | By Aishwarya |  223